This inventor holds 4 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent. Top assignees: Kyowa Hakko Kirin Co., Limited, Asahi Kasei Pharma Corporation. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (2015)
- Sunto-gun, JP (2013 - 2019)
Company Filing History:


Years Active: 2013-2019
Title: Yuji Ueno: Innovator in Antibody Stabilization
Introduction
Yuji Ueno is a prominent inventor based in Sunto-gun, Japan. He has made significant contributions to the field of biochemistry, particularly in the stabilization of antibodies. With a total of 4 patents to his name, Ueno's work has the potential to impact various medical applications.
Latest Patents
Ueno's latest patents include a method of stabilizing antibodies and a highly-purified soluble thrombomodulin. The first patent provides a method for suppressing the formation of soluble associations and chemically degraded products of antibodies in solution. It also introduces a solution-type antibody preparation that maintains stability by preventing the formation of insoluble aggregates. The second patent focuses on producing highly-purified soluble thrombomodulin with minimal host cell-originated proteins, enhancing its therapeutic potential.
Career Highlights
Throughout his career, Ueno has worked with notable companies such as Kyowa Hakko Kirin Co., Limited and Asahi Kasei Pharma Corporation. His experience in these organizations has allowed him to develop innovative solutions in the field of antibody research.
Collaborations
Ueno has collaborated with esteemed colleagues, including Takashi Kayashita and Atsushi Ishihara. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Yuji Ueno's innovative work in antibody stabilization showcases his dedication to advancing biochemistry. His patents reflect a commitment to improving medical treatments and enhancing the efficacy of therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile